Bang Chen personally holds 23.8 million shares of Aier Ophthalmology, but Hunan Aier Investment, which holds 4 1.65%, also holds 60 million shares of Aier Ophthalmology. Bang Chen actually holds 65.446 million shares, accounting for 65% of the total share capital. According to the issue price of 28 yuan/share, the stock market value also reached 65.438+83.2 million yuan.
In the story of getting rich on GEM, the most legendary one is Bang Chen, chairman of Aier Ophthalmology: a layman who doesn't know ophthalmology technology got on the GEM rich list by opening an eye hospital.
The introduction of Bang Chen's resume in Aier Ophthalmology Prospectus is extremely simple. Bang Chen, 44, founder of Aier Ophthalmology, graduated with a master's degree, and is a part-time MBA tutor of Hunan University. But behind this simple resume, Bang Chen has a very rich and legendary personal experience. Bang Chen is a soldier. After leaving the army, I have done equipment agency, cultural communication and real estate, and I have been involved in a wide range.
In China in the late 1990s, the reform and opening-up policy was further deepened, and the policy was once relaxed, allowing private capital to enter the medical field with higher threshold. This makes Bang Chen, who is struggling in the medical device industry, shine at the moment. He saw infinite business opportunities in the new medical policy, so he decided to enter the field of ophthalmology medical care, which was still very unpopular at that time.
"At that time, I entered the medical industry mainly to try new fields." Bang Chen played down the decision of that year, but now it seems that he has opened the door to a huge market with an estimated scale of 30 billion yuan.
From 65438 to 0997, Bang Chen spent 30,000 yuan in savings to cooperate with traditional public hospitals in the form of "hospital intermediate people's court" to set up ophthalmology department in public hospitals to do myopia examination and routine myopia surgery. Relying on the superior resources of public hospitals, he earned the first bucket of gold in his life.
But it didn't last long. In 2000, the state began to vigorously rectify the "Intermediate People's Court" of public hospitals. Bang Chen had to move out of public hospitals to find another way out, and opened the first specialized hospital in Shenyang, Liaoning Province on 200 1. Without the support of resources, the business of Aier Ophthalmology plummeted. In the meantime, because of poor business, Bang Chen's important partner and technical backbone of Aier Ophthalmology chose to leave.
However, things will eventually work out. After 2002, Bang Chen, who refused to admit defeat, chose to establish a chain hospital with others or units in adversity. At the beginning of 2003, Aier Ophthalmology opened four hospitals in Changsha, Chengdu, Wuhan and other places almost at the same time, and at the same time vigorously recruited troops. At this time, ophthalmology has become a hot specialty, and Aier's ophthalmology business is smooth, and its reputation is almost equal to that of Beijing tongji hospital and Sun Yat-sen University Eye Hospital.
Since then, Aier Ophthalmology has begun to extend its tentacles to first-tier cities such as Shanghai and Shenzhen and third-tier cities such as prefecture-level cities in Hunan. In just a few years, 119 chain eye hospitals have been opened in1provinces and cities across the country.
After Aier Ophthalmology landed on GEM, Bang Chen's value soared. From the initial 30,000 yuan to the present book wealth of 4.86 billion yuan, Bang Chen's wealth creation story has added a lot of inspirational colors to GEM.
As early as 2004, Bang Chen had contacted American venture capitalists and tried to enter Nasdaq for two years. However, at the last minute, Bang Chen thought that foreign capital could not understand the industry situation of domestic private hospitals well, so he resolutely gave up the NASDAQ dream.
The timing of the start-up of GEM just gave Aier Ophthalmology, which has made full preparations for listing, an opportunity to show its strength, and Bang Chen's dream of listing in A shares was realized. Not long ago, at the 9th Annual Forum on Venture Capital and Private Equity Investment in China hosted by Zero2IPO Group, Bang Chen, as the sole founder of the Growth Enterprise Market, entered the list of "Top China Venture Entrepreneurs 10 Supported by VC/PE in 2009", and Bang Chen's 2009 was a hit.
But behind the glory, Aier Ophthalmology has also been questioned by many voices. As the only "medical institution" listed company on the GEM, Aier Ophthalmology raised 938 million yuan for the first time, 2.76 times of the original plan of 340 million yuan, making it the company with the largest proportion of over-raised funds on the GEM. Some experts believe that over-raised funds can only lie in bank accounts for a period of interest, which is obviously not in line with the original intention of GEM to solve the financing difficulties of SMEs.
"As a chain hospital, we never worry about how to spend more money." Bang Chen responded to the market's doubts about its excessive financing with a series of plans. Bang Chen explained that the over-raised 600 million funds will also be used to build Aier Eye Hospital, which will definitely not be diversified. For the future, Bang Chen aims to erect the brand of Aier Ophthalmology in most provincial capitals within three years.
Neighbors pull the line in.
Bang Chen is a soldier. After he retired from the army, he worked as an equipment agent, engaged in cultural communication and set foot in real estate. In the 1990s, he took 30,000 yuan to Shanghai to work hard, rented in an alley, and met a neighbor who made a living by renting ophthalmic treatment equipment to the hospital. After several chats, Bang Chen, who had no industry experience, decided to enter the gold rush, and soon "found the feeling".
From 65438 to 0997, Bang Chen cooperated with public hospitals in the mode of "hospital-intermediate people's court" to set up ophthalmology department in public hospitals to do myopia examination and routine ophthalmic surgery. In those years, relying on the superior resources of public hospitals, Bang Chen earned the first bucket of gold. In 200 1 year, Bang Chen started his own business and opened the first specialized eye hospital in Shenyang, but his business plummeted. Bang Chen decided to make one last effort. In 2003, he also set up four hospitals in Changsha, Wuhan and Chengdu. The road of chain brand has brought Aier ophthalmology back to life, which is out of control.
The listing was originally aimed at Nasdaq.
Among the first 28 companies listed on GEM, Aier Ophthalmology, founded in 2003, is one of the few "age-appropriate" companies. In the past six years, from a "clinic-style" eye hospital with only 1500 square meters to a medical group with 19 chain stores, these can only be regarded as "smooth sailing" in Bang Chen's view, because at that time, Aier Ophthalmology had the opportunity to run brilliantly.
"In 2004, when Aier Ophthalmology was less than one year old, we were going to take the company to Nasdaq for listing," Chen Bangdun paused. "You may not believe it, but at that time we really talked seriously with American venture capitalists for two years, and they were very interested. We gave up at the last minute. " The reason for giving up was that Bang Chen thought that foreign capital could not well understand the industry situation of private hospitals in China at that time. "Private identity makes us the first person to eat crabs. There is no ready-made copy, come by yourself. "
However, the sudden demise of capital internationalization has attracted the attention of the International Finance Corporation (IFC) under the World Bank, which aims to promote the development of private enterprises in developing countries. In 2006, Bang Chen got a check for $8 million. At that time, Aier Ophthalmology was the only enterprise in China that obtained long-term low-interest loans from IFC. Although there is not much money, and it is only a loan, not a share, this step is the key to our listing. Since then, from the financial audit of Aier Ophthalmology to the direct drinking water and fire hydrants in the reception hall of the hospital, IFC has required the implementation of international standards. "Therefore, our listing is both easy and simple."
Share prices can prevent long-term investors from losing money.
The ease of listing is also reflected in the stock price on the day of listing. The issue price of Aier Ophthalmology was set as 28 yuan, with the opening price of 48.86 yuan on the first day. It once reached 72 yuan in intraday trading, and closed at 5 1.90 yuan on that day. After that, there were ups and downs, with little fluctuation.
"I am very satisfied with the performance of the stock price since listing. I think it is more reasonable for Aier Ophthalmology to spend more than 50 yuan. " However, some brokers pointed out in the research report that the reasonable price range of Aier Ophthalmology is from 30 yuan to 40 yuan. Bang Chen was a little excited about it. "Agents who have really contacted us or learned about our hospital on the spot will definitely not give such a low price. To be honest, many researchers who write these reports simply don't understand our industry. " When talking about the future trend of the company's share price, Bang Chen made a detour. "Because many funds have not started, private equity and retail investors are basically speculating now, so it will take a year to see the stock price trend of the entire GEM. Of course, for long-term investors, I can say here that Aier Ophthalmology will not let them lose money. "
Bang Chen believes that the gradual liberalization of the policy may be the biggest and longest-term benefit of Aier Ophthalmology in the future. Looking back, Bang Chen didn't want to talk about the geometric growth of personal wealth. "I don't care about the stock price every day now. The richest man on the GEM is said by others, but I don't count it myself. It's all wealth on the account. Taking a nap may be hundreds of millions more or hundreds of millions less. "
Super-raised chain to Beijing within three years
Compared with the company's share price and his own worth, Bang Chen has more important things to worry about at the moment: how to spend the over-raised 600 million yuan. "As a chain hospital, we never worry about how to spend more money," Bang Chen explained. "This 600 million will also be used to build Aier Eye Hospital, and we will never take diversified development." Bang Chen aims to establish the brand of Aier Ophthalmology in most provincial capitals within three years. "If it is Beijing, we will definitely arrive in three years."
Ambitious Bang Chen spends most of his time on airplanes, with the goal of "connecting the whole country within three years". It's normal to fly to three or four cities a day. The most unbearable thing about this change is that Bang Chen can't smoke on the plane. During the interview with reporters for more than an hour, Bang Chen received an independent director, a broker and a business partner, and smoked one cigarette after another for the rest of the time. Before 10, Bang Chen won't smoke. "After all, now that the company is listed, the pressure is a bit great."